Skip to main content

Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure

Tracking # 20-892131

Price not reported

There are no ratings for this course

CE Broker Reporting Reported automatically
Method Lecture
Dates Contact provider

Course overview

At the end of this presentation, the pharmacists will be able to: 1. Summarize current GDMT for heart failure 2. Describe the mechanism by which SGLT2 inhibitors are proposed to benefit heart failure patients 3. Review landmark trials related to SGLT2 inhibitors use in heart failure At the end of this presentation, pharmacy technicians will be able to: 1. Describe what SGLT2 inhibitors are 2. Define GDMT for heart failure

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Pharmacy

Pharmacist

1h General

Registered Pharmacy Technician

1h General

Disclosure statements

The speaker has no disclosures or conflicts of interest relevant to this presentation